RM Global Partners logo

RM Global Partners

North America, New York, United States, New York

Description

RM Global is an investment banking and strategic advisory firm .

Investor Profile

RM Global Partners has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series A (50%)
  • Series B (50%)

Country Focus

  • United States (50%)
  • Israel (50%)

Industry Focus

  • Biotechnology
  • Life Science
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does RM Global Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Consensus Business Group
Europe, England, United Kingdom, London
Co-Investments: 1
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
8VC
North America, California, United States, San Francisco
Co-Investments: 1
JVC Investment Partners
North America, Illinois, United States, Northbrook
Co-Investments: 1
HH
North America, California, United States, San Francisco
Co-Investments: 1
Chong Kun Dang Pharmaceutical Corp.
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Bukwang Pharmaceutical Co
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 2

What are some of recent deals done by RM Global Partners?

ImmPACT Bio

Camarillo, California, United States

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

BiotechnologyLife Science
Series BJan 20, 2022
Amount Raised: $139,855,923
ImmPACT Bio

Camarillo, California, United States

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

BiotechnologyLife Science
Series AAug 18, 2020
Amount Raised: $18,000,000
BIOMx

Ness Ziona, HaMerkaz, Israel

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

BiotechnologyHealth CareTherapeutics
Series BFeb 20, 2019
Amount Raised: $32,000,000
Mitoconix Bio

Jerusalem, Yerushalayim, Israel

Mitoconix Bio is pioneering a disease-modifying strategy of improving mitochondrial functions for treating neurodegenerative diseases.

BiotechnologyHealth CareLife Science
Series AJun 27, 2017
Amount Raised: $20,000,000